« Back to Record
Citation APA

Saji, S., McArthur, H., Ignatiadis, M., Bailey, A., El-Abed, S., Brandão, M., Metzger-Filho, O., Lai, C., Guillaume, S., Fumagalli, D., Agbor-Tarh, D., Seiller, A., Altarcheh Xifro, R., Honvault, V., Viale, G., DuFrane, C., Barata, T., Winer, E., Gelber, R. D., & Piccart-Gebhart, M. (2021). ALEXANDRA/IMpassion030: A phase 3 study of standard adjuvant chemotherapy with or without atezolizumab in patients with early-stage triple-negative breast cancer. Journal of clinical oncology, 39(15_suppl), TPS597-TPS597. doi:10.1200/JCO.2021.39.15_suppl.TPS597


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/401763

Saji, S., McArthur, H., Ignatiadis, M., Bailey, A., El-Abed, S., Brandão, M., Metzger-Filho, O., Lai, C., Guillaume, S., Fumagalli, D., Agbor-Tarh, D., Seiller, A., Altarcheh Xifro, R., Honvault, V., Viale, G., DuFrane, C., Barata, T., Winer, E., Gelber, R. D., & Piccart-Gebhart, M. (2021). ALEXANDRA/IMpassion030: A phase 3 study of standard adjuvant chemotherapy with or without atezolizumab in patients with early-stage triple-negative breast cancer. Journal of clinical oncology, 39(15_suppl), TPS597-TPS597. doi:10.1200/JCO.2021.39.15_suppl.TPS597